By Kyle Becker – November 2, 2021
A whistleblower has come forward with damning revelations about how vaccine-maker Pfizer ‘falsified data’ and manipulated clinical trials. Brook Jackson, a former clinical trial auditor who was fired after raising her concerns, came forward with inside information and documented evidence about Pfizer’s operations in a stunning new BMJ investigation conducted by Paul Thacker. The disturbing report sends up red flags that the FDA and Pfizer are engaging in massive fraud against the American people to justify vaccine mandates.
The Pfizer-BioNTech vaccine was ‘fully authorized‘ with much fanfare by the U.S. Food and Drug Administration in August, despite liability shields and other qualifiers making such an endorsement highly misleading. The Biden administration would seize on the announcement to issue an executive order for federal vaccine mandates. The FDA would go on to authorize the vaccines for children between 5 and 11 years old, in late October despite the objections of numerous medical experts.
But the clinical trials documentation that Pfizer submitted to the FDA has now been exposed as riddled with clinical trial misconduct and data reporting errors, according to BMJ’s investigation.
“In autumn 2020 Pfizer’s chairman and chief executive, Albert Bourla, released an open letter to the billions of people around the world who were investing their hopes in a safe and effective covid-19 vaccine to end the pandemic,” the report said.
“As I’ve said before, we are operating at the speed of science,” Bourla wrote ahead of the FDA’s authorization of the Pfizer vaccines.
“But, for researchers who were testing Pfizer’s vaccine at several sites in Texas during that autumn, speed may have come at the cost of data integrity and patient safety,” BMJ reports. “A regional director who was employed at the research organisation Ventavia Research Group has told The BMJ that the company falsified data, unblinded patients, employed inadequately trained vaccinators, and was slow to follow up on adverse events reported in Pfizer’s pivotal phase III trial.”
“Staff who conducted quality control checks were overwhelmed by the volume of problems they were finding,” the report adds. “After repeatedly notifying Ventavia of these problems, the regional director, Brook Jackson, emailed a complaint to the US Food and Drug Administration (FDA). Ventavia fired her later the same day. Jackson has provided The BMJ with dozens of internal company documents, photos, audio recordings, and emails.”
Brook Jackson, the Ventavia research director who blew the whistle on Pfizer, had a sterling background at the clinical auditing firm when the decision was made to fire her . .
Rose Rambles... 